mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.002 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.002 |